Dear CSS Members and Colleagues: This year the Annual CSS meeting will consider the impact of technology on shoulder surgery. In keeping with this theme I offer you some insight into the value proposition for robots in the orthopedic operating room. This comes from a post to LinkedIN which I thought I would share here. Robots are expensive! But if we measure the value to patients then Value = Outcome/Cost. If then we consider learning curves and experts vs low volume surgeons, the analysis becomes more convincing. Robots reduce variation from the mean when measuring outcomes. In so doing, it is conceivable that the learning curve effect is mitigated for our patients. In other words, the stra
Dear CSS Members and Colleagues: While it may seem trite to say that failure is a requirement for success, the enclosed short article sheds some light on data that proves failure is a necessary ingredient for success. From my point of view it shows courage to take risk and then success reflects resiliency. Consider this in the context of your own risk tolerance and it may affect your perspective. Kind Regards, JP Warner, MD Founder, CSS
Dear CSS Members and Colleagues: Depart for a moment from the world of surgery and consider an interesting Ted talk from Ray Dalio who built one of the greatest Hedge funds, Bridgewater (https://www.bridgewater.com/leadership/ray-dalio/) Most of us work in AMC’s or large Private groups or for large companies developing technology for Orthopedics. For the most part these are not institutions which reflect on decisions. In fact, most make decisions and implement from a Top-down perspective. This is in keeping with their historical structure and responsibility to their Boards. For the most part these are risk-averse organizations that frequently perform with high revenue and low margin returns.